Finance News

Humanigen Inc, Mirasol Resources Ltd, Arcadia Biosciences Inc, Asterion Cannabis Inc, Duos Technologies Group Inc, Mawson Resources Ltd UPDATE…

A glance at some of the day’s highlights from the Proactive Investors US and Canada newswires


() said that two abstracts on its promising key drug candidate lenzilumab will be presented at the upcoming annual meeting of the American Society of Hematology, in Florida. In a statement, the Burlingame, California, company said the two abstracts are focused on granulocyte-macrophage colony-stimulating factor (GM-CSF) gene knockout and GM-CSF neutralization with lenzilumab, the company’s proprietary Humaneered anti-human-GM-CSF immunotherapy. Both abstracts have been accepted for presentation at the American Society of Hematology on December 9, at the Orange County Convention Center, in Orlando, Florida. 

Mirasol Resources Ltd () (OTCMKTS:MRZLF) on Wednesday provided an update on exploration activities at five mining projects in Chile and Argentina. In Chile the company is working with (OCTMKTS:NCMGY) on both the Gorbea Project and Altazor Project in the Atacama Puna Region. Both projects are funded and operated by Newcrest. “Our partner Newcrest recently commenced drilling at Gorbea and we look forward to results from that program later in the year,” said CEO Norm Pitcher in statement. “With a full field season ahead, we expect that this year will be pivotal for this project.” At Gorbea, Mirasol said that Newcrest has recommenced drilling with 3,000 meters (m) of diamond drilling planned.

Asterion Cannabis Inc offered a bit of good news Wednesday, with its announcement that its Australian arm won a permit from the Toowoomba Regional Council to proceed with its Toowoomba Medicinal Cannabis project. In the simplest terms, the Toowoomba Council has bestowed its approval on Asterion Australia’s design proposals for the horticulture project, which includes glasshouses for cannabis processing and cultivation as well as a facility for the culturing of medicinal cannabis tissue and research labs. 

() CEO told shareholders on Wednesday that the company is making strategic headway in its mission to enhance the quality and nutritional content of crops. In a statement accompanying the Davis, California-based company’s third-quarter results, CEO Matthew Plavan told investors that Arcadia achieved important progress during the quarter in both product commercialization and continuing research and development in each of its three strategic crop categories – hemp, wheat and soy. 

Duos Technologies Group Inc () wants to help freight railroad companies wrest shipping business back from the trucking industry. Class 1 railroads, the largest category of railroad companies in North America, are in the midst of an arms race — to get trains moving faster, cut costs and make amends for years of bad service, according to a Wall Street Journal report last month. Saving railroads money is where Duos comes in. The company’s proprietary Railcar Inspection Portal technology uses an automated process to take real-time 360-degree images of railcars travelling at speeds of up to 120 miles per hour.

Mawson Resources Ltd () (OTCMKTS:MWSNF) has released the voting results from the company’s annual general meeting of shareholders held Wednesday. A total of 89,205,281 common shares were voted, representing 62.65% of issued and outstanding common shares. Shareholders voted in favour of all the items of business before the meeting, including setting the number of directors at seven and for the re-election of all director nominees. Following the meeting, the board of directors reappointed Michael Hudson as chairman and CEO, Dr Nicholas Cook as president, Nick DeMare as CFO, and Mariana Bermudez as corporate secretary. The board also appointed David Henstridge, Colin Maclean and Mark Saxon as members of the company’s audit committee.

Technology Inc () (OTCMKTS:NTTCF), which offers products and services that allow businesses to accept instant cryptocurrency payments, announced Wednesday it continues to advance on all key metrics used to track growth. In a statement, the Vancouver-based company said its processing volume in October was 12% greater than the month before and 7.6 times greater than in February. 

() (OTCMKTS:HRVOF) subsidiary Satipharm Ltd has received Health Canada’s permission to import its proprietary CBD Gelpell capsules for research and development. The decision allows Harvest One to begin compliance testing and analysis of the capsules, which are manufactured in Switzerland, in anticipation of full-scale production in Canada in 2020.

(NASDAQ:ACST) () announced that it will host a conference call at 1.00 pm Eastern Time on November 13 to discuss the Canadian company’s financial results for the fiscal second quarter ended September 30. Investors can access the conference call by dialing 844-369-8770, while international callers can dial into 862-298-0840. Acasti is developing an advanced Omega-3/phospholipid prescription drug called CaPre to treat hypertriglyceridemia (high levels of triglycerides in the blood), which is known to contribute to heart disease.

Inc () CEO Armando Anido said Wednesday that the third-quarter was a period of “progress and execution” for the company which has sufficient cash reserves as it heads into key trials. The Devon, Pennsylvania-based company revealed that, as of September 30, it had cash and cash equivalents of $77.5 million. Management believes the company’s $77.5 million war chest will be “sufficient” to fund operations beyond the expected “New Drug Application submission and potential approval of Zygel in Fragile X syndrome and into the second half of 2021.”

Ltd () (OTMKTS:OILFF), a group focused on industrial extraction to produce cannabinoids, revealed that its distillation plant was on pace to be completed by the end of this month (November) as the company outlined its wider aims for 2020 and beyond.  The firm has been granted eight patents, with 44 pending, for technology it believes to be the most efficient methods for producing THC and CBD distillate at scale. It received its Health Canada standard processor license on September 6 this year.

RNC Minerals () reported an improved financial performance in the third quarter, which was the first full three months of processing material at its Higginsville Mill acquired in June, which led to a 35% reduction in processing costs, it said. “In a very short time, RNC has evolved from a single mine producer subject to high-cost toll milling to a company with two producing mines feeding a low-cost centralized mill,” noted Paul Huet, chief executive of the firm, which operates the Beta Hunt mine in Australia.

Mojave Jane Brands Inc () (OTCMKTS:HHPHF) has hired Clearview Capital Consult for communications and strategic advisory services. The vertically-integrated cannabis company said Clearview will assist with the development and implementation of its capital markets and communications strategy, along with general strategic advisory.

() Wednesday hailed the increase in the global market for energy storage as it continues on its hunt for lithium and vanadium.  “The rise of renewables-plus projects parallels the skyrocketing forecasts for the electric vehicle market. New solar and wind projects demand increased energy storage systems infrastructure,” noted Doug Cole, the company’s chief executive. “Together, these indicators validate that there is significant demand for new, U.S.-based sources of critical battery metals like lithium, cobalt, nickel, manganese, vanadium, and graphite.”  

Holdings Corp () (OTCMKTS:HERTF) told investors it had completed the continuation out of British Columbia into Ontario after shareholder approval at a recent board meeting. The cannabis company said there would be no change in the daily business of the company as a result of the continuation. Heritage holds a portfolio of pot companies, including two licensed producers, an extraction company and a medicinal marijuana outfit.

(), a commercial provider of liquid biopsy tests for patients diagnosed with cancer, said Wednesday that it plans to release third-quarter results after the market closes on November 13. The San Diego-based company will host a conference call to discuss the results and answer questions at 4:30 pm ET (1:30 pm PT). To dial in, investors may call (855) 656-0927 in the US, (855) 669-9657 in Canada and (412) 902-4109 elsewhere internationally.

Holdings (NYSEAMERICAN:MTNB) said it will host a conference call and live webcast on November 13 at 8 am ET to discuss operational and financial results for the quarter ended September 30. Investors can dial 877-407-5976 or 412-902-0031 to be on the conference call. The webcast will be available on the company’s website. The New Jersey-based company’s lead product candidate is MAT9001 for the treatment of cardiovascular and metabolic conditions.

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button